A Review of Lower Urinary Tract Symptoms in Patients with Parkinson’s Disease

被引:0
作者
Anand V. Badri
Rajveer S. Purohit
Jason Skenazy
Jeffrey P. Weiss
Jerry G. Blaivas
机构
[1] State University of New York Downstate Medical Center,
[2] Institute for Bladder and Prostate Research,undefined
[3] Weill Cornell Medical College,undefined
来源
Current Urology Reports | 2014年 / 15卷
关键词
Parkinson’s disease; Lower urinary tract symptoms; Overactive bladder; BPH; Bladder outlet obstruction; Urinary symptoms;
D O I
暂无
中图分类号
学科分类号
摘要
To critically review recent literature on lower urinary tract symptoms (LUTS) in patients with Parkinson’s Disease.A literature search was conducted using the keywords LUTS, urinary symptoms, non-motor, and Parkinson’s disease (PD) via the PubMed/Medline search engine. In the literature, we critically examined lower urinary symptoms in Parkinson’s patients by analyzing prevalence, pathogenesis, urinary manifestations, pharmacologic trials and interventions, and prior review articles. The data collected ranged from 1986 to the present with an emphasis placed on recent publications.The literature regards LUTS in PD as a major comorbidity, especially with respect to a patient’s quality of life. Parkinson’s patients experience both storage and voiding difficulties. Storage symptoms, specifically overactive bladder, are markedly worse in patients with PD than in the general population. Surgical management of prostatic obstruction in PD can improve urinary symptoms. Multiple management options exist to alleviate storage LUTS in patients with PD, ranging from behavioral modification to surgery, and vary in efficacy.Lower urinary tract dysfunction in PD may be debilitating. Quality of life can be improved with a multi-pronged diagnosis-specific approach to treatment that takes into consideration a patient’s ability to comply with treatment. A stepwise algorithm is presented and may be utilized by clinicians in managing LUTS in Parkinson’s patients.
引用
收藏
相关论文
共 130 条
[31]  
Holliger S(2011)Botulinum toxin type A in patients with Parkinson’s disease and refractory overactive bladder J Urol 186 960-8
[32]  
Schletterer K(2014)Onabotulinumtoxin A office treatment for neurogenic bladder incontinence in Parkinson’s disease Urology 83 22-42
[33]  
Berger Y(2013)le Comité de neuro-urologie de l’Association française d’urologie. “Lower urinary tract dysfunctions in parkinsonian syndromes: a review by the Neuro-Urology Comittee of the French Association of Urology.” [Article in French] Prog Urol 23 296-7
[34]  
Blaivas JG(2013)Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson’s syndromes Prog Urol 23 936-83
[35]  
DeLaRocha ER(1988)Post-prostatectomy continence in the parkinsonian patient: the significance of poor voluntary sphincter control J Urol 140 117-undefined
[36]  
Salinas EM(2009)Benign prostatic obstruction and parkinson’s disease – should transurethral resection of the prostate be avoided? J Urol 181 2209-undefined
[37]  
Ragab MM(2008)Augmentation Cystoplasty: what are the indications? Curr Urol Rep 9 452-undefined
[38]  
Mohammed ES(2013)The impact of deep brain stimulation on the nonmotor symptoms of Parkinson’s disease J Neural Transm. 120 639-undefined
[39]  
Siegl E(2012)Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson’s disease Parkinsonism Relat Disord 18 994-undefined
[40]  
Lassen B(2012)Bladder dysfunction in advanced Parkinson’s disease Neurourol Urodyn. 31 1279-undefined